Nme<sub>2</sub> Cas9-mediated therapeutic editing in inhibiting angiogenesis after wet age-related macular degeneration onset.

Clin Transl Med · 2023 · PMC10440058 · PMID 37598400

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

No significant difference was observed in these groups, compared to the negative control, while the CNV area with Nme 2 Cas9 ‐Vegfa treatment showed a decreasing trend (Figure 3B, C ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.